P-Ureidopropionase was purified 1000-fold over the initial rat liver extract, using heat treatment, ammonium sulfate fractionation, CM-Sepharose CL-6B, DEAE-Sepharose CL-6B, hydroxyapatite and Sephacryl S-300 chromatographies. The purified enzyme was shown to be homogeneous by gel electrophoresis both in the presence and absence of sodium dodecyl sulfate. Its molecular mass, determined by gel filtration and sucrose density gradient centrifugation, was 327000 9000 and 323000 5 13000 respectively, and the subunit molecular mass was 54000 _+ 600. The pH optimum for enzyme activity was 7.0 and PI was 6.4. The enzyme catalyzed the amidohydrolysis of N-carbamoyl-P-alanine and N-carbamoyl-DL-P-aminoisobutyrate but did not catalyze that of other ureido compounds including N-carbamoyl-DL-aspartate.With N-carbamoyl-P-alanine and N-carbamoyl-DL-P-aminoisobutyrate as substrate, the enzyme exhibited positive cooperativity with a Hill coefficient h = 2. The enzyme activity was proportional to the enzyme concentration between 0.2 nM and 0.5 pM. Arrhenius plots of the influence of temperature on the catalytic activity of the enzyme showed a sharp break at 19 "C.It is well known that uracil catabolizes to p-alanine via dihydrouracil and N-carbamoyl-P-alanine. /?-Ureidopropionase (N-carbamoyl-P-alanine amidohydrolase) is the last of the uracil-degradative enzymes [l, 21. The key role of uracil metabolism may be to regulate the pyrimidine pool. Canellakis [3] and Fritzson [4, 51 proposed that the first enzyme of the pathway, dihydrouracil dehydrogenase, was rate-limiting for pyrimidine degradation. Under limited conditions, however, P-ureidopropionase becomes ratelimiting [6, 71.During differentiation [8] and fetal and neonatal development 191 there is an increase in the activity of the catabolic pathway of pyrimidine and the activity of P-ureidopropionase increases in parallel with the overall pathway. In contrast the synthetic utilization of uridine into RNA declined sharply with fetal and neonatal development [9]. From these findings, 0-ureidopropionase might have an important function in uracil metabolism. We purified P-ureidopropionase from rat liver and studied its properties. In the course of the studied we ascertained the allosteric properties of the enzyme. MATERIALS AND METHODS MaterialsAll chemicals used were of analytical grade and were purchased from Nakarai Chemicals Ltd (Kyoto) unless otherwise stated. N-Carbamoyl-P-alanine and other carbamoyl Correspondence to N. Tamaki, Laboratory of Nutritional Chemistry, Faculty of Nutrition, Kobe-Gakuin University, Nishi-ku, Kobe, Japan 673Enzymes. p-Ureidopropionase or N-carbamoyl-P-alanine amidohydrolase (EC 3.5.1.6); dihydrouracil dehydrogenase (EC 1.3.1.2); dihydropyrimidinase (EC 3.5.2.2); RNA nucleotidyltransferase (EC 2.7.7.6); pyruvate kinase (EC 2.7.1.40); lactate dehydrogenase (EC 1.1.1.27); alcohol dehydrogenase (EC 1.1.1.1).compounds were products of Sigma Chemicals. CMSepharose CL-6B, DEAE-Sepharose CL-6B and Sephacryl S-300 were obtained from Pharmacia and hydroxy...
The secretin injection test has been proved to be useful in the diagnosis of gastrinoma in vivo. Fresh gastrinoma cells were cultured for a short time in vitro and then stimulated with secretin. A rise in the gastrin concentration in the culture medium was observed within 10 min after the addition of secretin. This fact may be evidence that gastrinoma cells have receptors which bind with secretin resulting in the release of gastrin.
When 6‐azauracil was subcutaneously injected, β‐aminoisobutyric acid and β‐alanine contents were increased 22 and 61‐fold, respectively, in rat liver. Incorporation of [methyl‐14Cithymine into β‐aminoisobutyric acid was increased to 42‐fold by 6‐azauracil treatment. The absolute configuration of this amino acid was proved to be the (R)‐form by means of a gas‐chromatographic technique. 6‐Azauracil inhibited β‐alanine‐pyruvate aminotransferase activity with an I 50 of approx. 2.5 mM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.